Oglesby A, et al. Patient-reported outcomes after switching to a two-drug regimen of dolutegravir + rilpivirine: Week 100 results from the SWORD-1 and SWORD-2 studies. Abstract P101. HIV/Drug Therapy Glasgow 2018.
Intraveneuze versus orale antibiotica voor eradicatie van 'P. aeruginosa' bij cystische fibrose
jan 2021 | CF